Breaking News

EnGenius Brings AI-Powered Analytics and Sophisticated Cloud Management to Existing ONVIF Cameras Introducing the 2026 Blade 16 ASRock Unveils Intel Arc Pro B70 Graphics Cards, Redefining Professional Workspaces Sony Unveils New BRAVIA Theatre Home Audio Lineup for Enhancing Home Cinema Experience GoPro to Unveil New Generation of Cameras at the April 2026 NAB Show

logo

  • Share Us
    • Facebook
    • Twitter
  • Home
  • Home
  • News
  • Reviews
  • Essays
  • Forum
  • Legacy
  • About
    • Submit News

    • Contact Us
    • Privacy

    • Promotion
    • Advertise

    • RSS Feed
    • Site Map

Search form

FDA Approves Blood Sugar Monitor Device That Requires no Finger Prick Tests

FDA Approves Blood Sugar Monitor Device That Requires no Finger Prick Tests

Consumer Electronics Sep 29,2017 0

The U.S. Food and Drug Administration (FDA) has approved the first continuous blood sugar monitor for diabetics that doesn't need backup finger prick tests.

Abbott's FreeStyle Libre system measures glucose levels through a small sensor applied to the back of your upper arm. The sensor, which is the size of two stacked quarters, provides real-time glucose readings for up to 10 days, both day and night. The sensor can also read glucose levels through clothes.

The FreeStyle Libre system provides people with diabetes a real-time glucose result, an 8-hour historical trend, and a trend arrow showing the direction their glucose is going. The touch-screen reader holds up to 90 days of data, which allows people to track their glucose levels over time.

Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor. The method is both uncomfortable and pricey for the patient, discouraging the daily monitoring of their blood sugar.

Abbott's device was approved for adults with Type 1 or Type 2 diabetes and should be available in pharmacies across the U.S. within months. The company did not disclose the price of the reader or the sensors.

Abbott's system can't be used with an insulin pump, at least for now.

Tags:
Previous Post
Apple's Semiconductor Ambitions Could Disrupt Supply Chain in the Near Future
Next Post
Elon Musk Wants to Take you Anywhere on Earth in One Hour, Sees First cargo Mission to Mars by 2022

Related Posts

Latest News

EnGenius Brings AI-Powered Analytics and Sophisticated Cloud Management to Existing ONVIF Cameras
Enterprise & IT

EnGenius Brings AI-Powered Analytics and Sophisticated Cloud Management to Existing ONVIF Cameras

Introducing the 2026 Blade 16
Enterprise & IT

Introducing the 2026 Blade 16

ASRock Unveils Intel Arc Pro B70 Graphics Cards, Redefining Professional Workspaces
GPUs

ASRock Unveils Intel Arc Pro B70 Graphics Cards, Redefining Professional Workspaces

Sony Unveils New BRAVIA Theatre Home Audio Lineup for Enhancing Home Cinema Experience
Consumer Electronics

Sony Unveils New BRAVIA Theatre Home Audio Lineup for Enhancing Home Cinema Experience

GoPro to Unveil New Generation of Cameras at the April 2026 NAB Show
Cameras

GoPro to Unveil New Generation of Cameras at the April 2026 NAB Show

Popular Reviews

be quiet! Dark Mount Keyboard

be quiet! Dark Mount Keyboard

be quiet! Light Mount Keyboard

be quiet! Light Mount Keyboard

Akaso 360 Action camera

Akaso 360 Action camera

Dragon Touch Digital Calendar

Dragon Touch Digital Calendar

be quiet! Pure Loop 3 280mm

be quiet! Pure Loop 3 280mm

Noctua NF-A12x25 G2 fans

Noctua NF-A12x25 G2 fans

Arctic Liquid Freezer III 360 Pro Argb

Arctic Liquid Freezer III 360 Pro Argb

Soft2bet and the unseen hardware that makes instant play possible

Soft2bet and the unseen hardware that makes instant play possible

Main menu

  • Home
  • News
  • Reviews
  • Essays
  • Forum
  • Legacy
  • About
    • Submit News

    • Contact Us
    • Privacy

    • Promotion
    • Advertise

    • RSS Feed
    • Site Map
  • About
  • Privacy
  • Contact Us
  • Promotional Opportunities @ CdrInfo.com
  • Advertise on out site
  • Submit your News to our site
  • RSS Feed